# US 2022/0277241 A1 · Method and system for assigning resources in product development

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0277241 A1
- Document ID: US20220277241A1
- Status: Published application
- Kind: A1
- Application number: 17/636,503
- Filed: 2020-08-18
- Published: 2022-09-01
- Earliest claimed: 2019-08-18
- Assignees: Aizen Algo Private Limited
- Applicants: Aizen Algo Private Limited
- Inventors: Usha Balakrishnan BITHUNSHAL; Ramdas MANAKKOTE; Srinivas Varma MUDUNURI; Varma Srinivasa Rajasekara RUDRARAJU
- Web page: https://patentgrep.com/patent/US20220277241A1

## CPC

- G06Q 10/06: Resources, workflows, human or project management; Enterprise or organisation planning; Enterprise or organisation modelling
- G06Q 10/06313: {Resource planning in a project environment}
- G06Q 10/08: Logistics, e.g. warehousing, loading or distribution; Inventory or stock management
- G06Q 50/04: Manufacturing
- G16H 20/10: relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H 40/20: for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
- G06Q: INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

The present disclosure relate to a method and system to assign resources for development of a pharmaceutical product. The method comprises receiving one or more inputs associated with the pharmaceutical product from a user and determining a complexity score of the pharmaceutical product based on the one or more inputs received. The method further comprises classifying the pharmaceutical product based on the complexity score and determining a timeline for development of the pharmaceutical product based on the classification. The method also comprises assigning the resources for development of the pharmaceutical product based on the determination, wherein the resources include at least one of project members and equipment's required for development of the pharmaceutical product.

## Claims

### Claim 1

A method of assigning resources for development of a pharmaceutical product, comprising:
receiving one or more inputs associated with the pharmaceutical product from a user;
determining a complexity score of the pharmaceutical product based on the one or more inputs received;
classifying the pharmaceutical product based on the complexity score;
determining a timeline for development of the pharmaceutical product based on the classification; and
assigning the resources for development of the pharmaceutical product based on the determination, wherein the resources include at least one of project members and equipment's required for development of the pharmaceutical product.

### Claim 2 (depends on 1)

The method as claimed in claim 1, wherein the one or more inputs includes name of the pharmaceutical product, one or more categories of the pharmaceutical product, and name of the user, and wherein the one or more categories includes at least one of Active pharmaceutical ingredient (API), dosage form, manufacturing process, formulation composition, stability, analytical testing, and reference product.

### Claim 3 (depends on 2)

The method as claimed in claim 2, wherein determining the complexity score of the pharmaceutical product includes:
comparing one or more properties of each category with a plurality of properties of one or more historical pharmaceutical products stored in a data repository;
assigning a criticality score for each category based on the comparison; and
determining the complexity score of the pharmaceutical product based on the criticality score of each category, and a weightage value corresponding to each category.

### Claim 4 (depends on 3)

The method as claimed in claim 3, wherein assigning the criticality score for each category comprises:
assigning a criticality score for each category when the one or more properties of the pharmaceutical products best matches with the plurality of properties of the one or more historical pharmaceutical products.

### Claim 5 (depends on 3)

The method as claimed in claim 3, wherein assigning the criticality score for each category comprises:
classifying the plurality of properties of the one or more historical pharmaceutical products to one of continuous and discrete properties if the one or more properties of the pharmaceutical products do not match with the plurality of properties of the one or more historical pharmaceutical products;
normalizing values of the continuous properties into corresponding values of the discrete properties; and
assigning a criticality score of the normalized values of discrete properties to each category.

### Claim 6 (depends on 3)

The method as claimed in claim 3, further comprising:
receiving an actual complexity score from the user as input after development of the pharmaceutical product; and
dynamically adjusting the weightage value corresponding to each category based on comparison of the complexity score with the actual complexity score received.

### Claim 7 (depends on 1)

The method as claimed in claim 1, wherein determining the timeline for development of the pharmaceutical product includes:
identifying a timeline template for the pharmaceutical product based on the classification, wherein the classification includes one of simple Immediate Release (IR), complex Immediate Release (IR), simple Extended Release (ER), and complex Extended Release (ER), wherein the timeline template comprises a number of project member days and equipment days required for development of the pharmaceutical product;
determining the resources required based on the complexity score and current workload of the resources;
updating the timeline template identified based on the determination; and
determining the timeline for development of the pharmaceutical product based on the timeline template updated.

### Claim 8 (depends on 1)

The method as claimed in claim 1, further comprising updating the data repository with the assigned resources upon receiving confirmation from the user.

### Claim 9 (depends on 2)

The method as claimed in claim 2, further comprising:
comparing the name of the pharmaceutical product with name of the one or more historical pharmaceutical products; and
determining count of the one or more categories of the pharmaceutical product based on the comparison, so as to input the one or more categories required by the user.

### Claim 10 (depends on 2)

The method as claimed in claim 2, wherein the one or more categories of the pharmaceutical product are automatically determined if the name of the pharmaceutical product matches with name of one or more historical pharmaceutical products and displayed to the user for receiving confirmation from the user.

### Claim 11

A system to assign resources for development of a pharmaceutical product, comprising:
a memory; and
a processor, coupled to the memory, and is configured to:
receive one or more inputs associated with the pharmaceutical product from a user;
determine a complexity score of the pharmaceutical product based on one or more inputs received;
classify the pharmaceutical product based on the complexity score;
determine a timeline for development of the pharmaceutical product based on the classification; and
assign the resources for development of the pharmaceutical product based on the determination, wherein the resources include at least one of project members and equipment's required for development of the pharmaceutical product.

### Claim 12 (depends on 11)

The system as claimed in claim 11, wherein the one or more inputs includes name of the pharmaceutical product, one or more categories of the pharmaceutical product, and name of the user, and wherein the one or more categories includes at least one of Active pharmaceutical ingredient (API), dosage form, manufacturing process, formulation composition, stability, analytical testing, and reference product.

### Claim 13 (depends on 12)

The system as claimed in claim 12, wherein to determine the complexity score of the pharmaceutical product, the processor is configured to:
compare the one or more properties of each category with a plurality of properties of one or more historical pharmaceutical products stored in a data repository;
assign a criticality score for each category based on the comparison; and
determine the complexity score of the pharmaceutical product based on the criticality score of each category, and a weightage value corresponding to each category.

### Claim 14 (depends on 13)

The system as claimed in claim 13, wherein the processor is configured to assign the criticality score for each category by:
assigning a criticality score for each category when the one or more properties of the pharmaceutical products best matches with the plurality of properties of the one or more historical pharmaceutical products.

### Claim 15 (depends on 13)

The system as claimed in claim 13, wherein the processor is configured to assign the criticality score for each category by:
classifying the plurality of properties of the one or more historical pharmaceutical products to one of continuous and discrete properties when the one or more properties of the pharmaceutical products do not match with the plurality of properties of the one or more historical pharmaceutical products;
normalizing values of the continuous properties into corresponding values of the discrete properties; and
assigning a criticality score of the normalized values of discrete properties to each category.

### Claim 16 (depends on 13)

The system as claimed in claim 13, wherein the processor is configured to:
receive an actual complexity score from the user as input after development of the pharmaceutical product; and
dynamically adjust the weightage value corresponding to each category based on comparison of the complexity score with the actual complexity score received.

### Claim 17 (depends on 11)

The system as claimed in claim 11, wherein to determine the timeline for development of the pharmaceutical product, the processor is configured to:
identify a timeline template for the pharmaceutical product based on the classification, wherein the classification includes one of simple Immediate Release (IR), complex Immediate Release (IR), simple Extended Release (ER), and complex Extended Release (ER), wherein the timeline template comprises a number of project member days and equipment days required for development of the pharmaceutical product;
determine the resources required based on the complexity score and current workload of the resources;
update the timeline template identified based on the determination; and
determine the timeline for development of the pharmaceutical product based on the timeline template updated.

### Claim 18 (depends on 11)

The system as claimed in claim 11, wherein the processor is configured to update the date repository with the assigned resources upon receiving confirmation from the user.

### Claim 19 (depends on 12)

The system as claimed in claim 12, wherein processor is configured to:
compare the name of the pharmaceutical product with name of the one or more historical pharmaceutical products; and
determine count of the one or more categories of the pharmaceutical product based on the comparison, so as to input the one or more categories required by the user.

### Claim 20 (depends on 12)

The system as claimed in claim 12, wherein the processor is configured to:
automatically determine the one or more categories of the pharmaceutical products if the name of the pharmaceutical product matches with name of one or more historical pharmaceutical products; and
display the determined one or more categories for receiving confirmation from the user.
